20250228845. Combination Dosage F (AXSOME THERAPEUTICS, .)
COMBINATION DOSAGE FORMS AND ADMINISTRATION THEREOF
Abstract: this disclosure relates to methods of administering bupropion, such as s-bupropion or r-bupropion, in conjunction with tetrabenazine, alpha-dihydrotetrabenazine, or beta-dihydrotetrabenazine to a human being. dosage forms, drug delivery systems, and methods related to tetrabenazine, alpha-dihydrotetrabenazine, or beta-dihydrotetrabenazine and bupropion, such as s-bupropion or r-bupropion, are also disclosed.
Inventor(s): Herriot Tabuteau
CPC Classification: A61K31/4745 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250228845